Oncostatin M (OSM), an IL-6 subfamily cytokine, inhibits proliferation and
causes morphological changes in many tumor cell lines, GM-CSF, phorbol-12-m
yristate-13-acetate (PMA), and lipopolysaccharide (LPS) induce OSM expressi
on. To investigate the mechanisms governing OSM promoter activity, we have
cloned and partially sequenced an 8.5 kb fragment of human genomic DNA imme
diately 5' of the OSM coding region and mapped the transcription start site
. Transient transfection assays with a series of 5' deletion plasmids demon
strated maximal reporter activity in U937 cells with a minimum 304 bp const
ruct, The 5'-proximal region of the human OSM gene contains a C/EBP consens
us element around -45 bp and several GC-rich regions around -60, each of wh
ich is responsible for basal promoter activity. Electrophoretic mobility sh
ift assay coupled with supershift analysis confirmed the presence of a cis-
acting binding site for activated STAT5 complexes following GM-CSF treatmen
t. Furthermore, transient transfection studies demonstrated a loss of GM-CS
F responsiveness in reporter constructs containing mutations within this ST
AT element, Our results establish that C/EBP and an as yet unidentified GC-
rich binding transcription factor are responsible for basal OSM promoter ac
tivity, while GM-CSF-stimulated OSM expression is driven by activated STAT5
complexes binding to a cis-acting STAT element on the OSM promoter.